The United States Patent and Trademark Office (USPTO) has published the trademark application TM99722596 for the mark ONCOTALK. This publication opens a period for opposition to the registration of the mark. The application seeks to cover consulting services in the field of oncology, specifically focusing on connecting healthcare professionals to share insights and discuss advancements.

This is a trademark publication, not a regulatory rule or guidance. While it pertains to healthcare services, it does not impose new compliance obligations on healthcare providers. Companies or individuals intending to oppose the trademark registration must do so within the designated opposition period, details of which are typically found in USPTO procedural rules.